Meglitinide analogues for type 2 diabetes mellitus (Review)
BACKGROUND: In type 2 diabetes mellitus, impairment of insulin secretion is an important component of the disease. Meglitinide analogues are a class of oral hypoglycaemic agents that increase insulin secretion, in particular, during the early phase of insulin release. OBJECTIVES: The aim of this re...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2009-01-21.
|
| Subjects: | |
| Online Access: | Get fulltext |